Advertisement

Topics

Thoratec Company Profile

18:57 EDT 24th September 2017 | BioPortfolio

Thoratec Corporation is engaged in the research, development, manufacturing and marketing of medical devices for circulatory support, vascular graft, blood coagulation and skin incision applications. The Thoratec® Ventricular Assist Device (VAD) System approved for left, right, or total heart support and can be used as both a bridge-to-transplant and for recovery from open-heart surgery. More than 4,300 of these devices have been used in the treatment of over 2,800 patients worldwide. With the introduction of the Implantable Ventricular Assist Device (IVAD(tm)), Thoratec delivers the first and only implantable VAD for left, right and biventricular support. The IVAD is for bridge-to-heart transplantation and for post-cardiotomy recovery. Over 60 IVADs have been implanted worldwide. The company is also a leader in implantable left ventricular assist devices (LVAD). Its pneumatic and electric HeartMate® LVADs, which have been implanted in more than 4,100 patients worldwide, are implanted alongside the natural heart and take over the pumping function of the left ventricle for patients whose hearts are too damaged or diseased to produce adequate blood flow.

Location

6035 Stoneridge Drive
Pleasanton
CA
94588
United States of America

Contact

Phone: 925-847-8600
Fax: 925-847-8574


News Articles [11 Associated News Articles listed on BioPortfolio]

Thoratec Presentation At Barclays Global Healthcare Conference To Be Webcast

PLEASANTON, Calif., March 11, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failin...

Thoratec Presentation At Canaccord Genuity Growth Conference To Be Webcast

PLEASANTON, Calif., Aug. 4, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing heart...

Thoratec Presentation at Leerink Swann Global Healthcare Conference to Be Webcast

PLEASANTON, Calif., Feb. 11, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...

Thoratec Presentation At Morgan Stanley 2013 Health Care Conference To Be Webcast

PLEASANTON, Calif., Aug. 22, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...

Thoratec Presentation At J.P. Morgan Healthcare Conference To Be Webcast

PLEASANTON, Calif., Jan. 2, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore fail...

Thoratec Announces Presentations at Upcoming Investor Conferences

PLEASANTON, Calif., Sept. 6, 2011 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hear...

FDA issues Class 1 recall of Abbott-Thoratec LVAS controller

The U.S. Food and Drug Administration (FDA) has announced a Class 1 recall of the HeartMate II LVAS Pocket System Controller from Abbott-Thoratec.

HeartMate II LVAS Pocket System Controller by Abbott-Thoratec: Class I Recall - Due to Risk of Patient Injury and/or Death during Backup Controller Exchange

[Posted 05/23/2017] AUDIENCE: Cardiology, Risk Manager, Nursing, Patient ISSUE: Abbott-Thoratec has received a total of 70 reports of incidents in which the controller has malfunctioned after an excha...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Durable Biventricular Support Using Right Atrial Placement of the HeartWare HVAD.

Patients with Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) levels 1-2 who either have or are at risk for right ventricular failure face significant morbidity and mort...

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Thoratec

Thoratec Corporation is engaged in the research, development, manufacturing and marketing of medical devices for circulatory support, vascular graft, blood coagulation and skin incision applications. ...

Thoratec Corporation

More Information about "Thoratec" on BioPortfolio

We have published hundreds of Thoratec news stories on BioPortfolio along with dozens of Thoratec Clinical Trials and PubMed Articles about Thoratec for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Thoratec Companies in our database. You can also find out about relevant Thoratec Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record